Vincristine therapy of idiopathic and secondary thrombocytopenias.
D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D001772:Blood Cell Count; D001792:Blood Platelets; D001855:Bone Marrow Diseases / Q000150:complications; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013156:Splenectomy; D013921:Thrombocytopenia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D005938:Glucocorticoids; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone